DKCM
ACHN

Davidson Kempner Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Davidson Kempner Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-918,942
Closed -$5.54M – 222
2019
Q4 		$5.54M Buy
+918,942
New +$5.32M 0.12% 112

Davidson Kempner Capital Management's ACHN Position: Q1 2020 in Review

Davidson Kempner Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 918,942 shares — an estimated $5.54M sold.

Davidson Kempner Capital Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $5.54M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Davidson Kempner Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 918,942 Achillion Pharmaceuticals shares in Q1 2020, an estimated $5.54M.
  • Davidson Kempner Capital Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Achillion Pharmaceuticals position peaked at $5.54M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2020, filed 15 May 2020.